NKGEN BIOTECH INC (NKGN) Stock Balance Sheet
USA - NASDAQ:NKGN - US65488A1016 - Common Stock
0.1913 USD
-0.32 (-62.91%)
0.19 USD
0 (-0.68%)
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | 26.00K | 600.00K | 1.70M | null | |||
| Cash Equivalents | 79.00K | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 23.00K | 26.00K | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 1.15M | 1.88M | 200.00K | 800.00K | null | |||
| Total Current Assets | 1.25M | 1.93M | 900.00K | 2.50M | null | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.31M | 14.46M | null | null | null | |||
| Investments And Advances | null | null | 173.50M | 171.70M | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 93.00K | 92.00K | null | null | null | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 14.40M | 14.55M | 173.50M | 171.70M | undefined | |||
| TOTAL ASSETS | 15.65M | 16.48M | 174.40M | 174.20M | null | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 25.00K | 0 | 0 | 0 | null | |||
| Current Portion Of LT Debt. | 17.25M | 9.99M | null | null | null | |||
| Accrued Expenses | 2.45M | 2.27M | 2.50M | 1.70M | null | |||
| Accounts Payable | 12.69M | 11.12M | 200.00K | 100.00K | null | |||
| Other Current Liabilities | 18.99M | 16.15M | 200.00K | 200.00K | null | |||
| Total Current Liabilities | 51.41M | 39.45M | 2.80M | 1.90M | null | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.37M | 9.93M | 0 | 0 | null | |||
| Deferred Taxes/Income | 33.00K | 33.00K | null | null | null | |||
| Other Non-Current Liabilities | 23.55M | 25.76M | 2.50M | 11.60M | null | |||
| Total Non-Current Liabilities | 33.96M | 35.72M | 2.60M | 11.60M | undefined | |||
| TOTAL LIABILITIES | 85.36M | 75.17M | 5.40M | 13.50M | null | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -183.60M | -162.13M | -4.20M | -10.90M | null | |||
| Additional Paid In Capital | 124.59M | 121.73M | 0 | 0 | null | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 3.00K | 2.00K | 173.20M | 171.60M | null | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -10.71M | -18.29M | null | null | null | |||
| Shares Outstanding | 25.77M | 22.81M | 21.50M | 21.50M | null | |||
| Tangible Book Value per Share | -2.7088 | -2.5777 | 7.8605 | 7.4744 | null | |||
| Total Shareholders' Equity | -69.72M | -58.69M | 169.00M | 160.70M | null | |||
| TOTAL LIABILITIES AND EQUITY | 15.65M | 16.48M | 174.40M | 174.20M | null | |||
| Statistics | ||||||||
| Debt/Equity | -0.15 | -0.17 | N/A | N/A | N/A | |||
| Current Ratio | 0.02 | 0.05 | 0.32 | 1.32 | N/A | |||
| Return On Assets (ROA) | -564.01% | -503.33% | 2.61% | -0.57% | N/A | |||
| Return On Equity (ROE) | N/A | N/A | 2.69% | -0.62% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21